Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions
Acute Ischemic StrokeLarge Vessel OcclusionNeuroprotective DrugsEndovascular Treatment
Interventions
DRUG

Semaglutide 0.5 mg

0.5mg semaglutide injection before and 1 week after endovascular treatment.

OTHER

Standard medical treatment

Standard medical management

Trial Locations (1)

Unknown

The First Affiliated Hospital of University of Science and Technology of China, Hefei

All Listed Sponsors
collaborator

Chinese University of Hong Kong

OTHER

lead

Wei Hu

OTHER